Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve In terms of Regulation ....
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed stock exchanges that its Board of Directors will meet on Monday, February 9, 2026. The main item on the agenda is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company is listed on both BSE (scrip code 543434) and NSE (symbol SUPRIYA). As per insider trading rules, the trading window for designated persons and their immediate relatives has been closed since January 1, 2026, and will reopen 48 hours after the results are declared.
This is a standard pre-results intimation and does not by itself impact the stock price. Investors should watch the actual Q3 FY26 numbers on February 9, 2026 for revenue, margins, and growth trends in the API business.